Feed AXGN
AX

AxoGen, Inc.

AXGN · NASDAQ

$45.93 +1.83% (+$0.83)
1M -6.70%
Market Cap $2.47B
P/E Ratio -
Div. Yield -
ROE 17.88%

Bulios Fair Price

$29.55

35.7% downside

Trenutna cena

$45.93

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica AXGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Moderate
4/9
Valuation
0 /100
Expensive
P/B 9.64x
P/FCF 977.54x
P/S 9.83x
Growth
92 /100
Growing
Book val. growth 8.46%
Rev. growth 17.57%
FCF growth N/A
Profitability
24 /100
Weak
Net margin 13.36%
Op. margin 5.12%
FCF margin 1.01%
Quality
10 /100
Poor
ROE 17.88%
ROA 11.00%
Asset turnover 0.82x
Debt
69 /100
Low
Current ratio 6.60x
Int. coverage -1.71x
Debt/Equity 0.08x
Stability
58 /100
Moderate
Rev. volatility 2.74%
EPS volatility 52.99%
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o AXGN
Online

O podjetju

AxoGen, Inc. (AXGN) is a biotechnology company focused on the development and manufacture of innovative therapeutic products and therapies for peripheral nerve repair. Their products are designed to aid patients with peripheral nerve damage caused by traumatic injuries or surgical procedures. AxoGen specializes in utilizing advanced technologies and biological materials to support nerve cell regeneration and restore nervous system function. The company is a leading player in the field of regenerative medicine and is focused on providing innovative solutions for the treatment of patients with nerve injuries. Shares of AxoGen, Inc. (AXGN) may be attractive to investors seeking opportunities in the biotechnology and regenerative medicine sector.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Michael D. Dale

Employees

622

Headquarters

Alachua

Prihajajoči dogodki

04 NOV.

Earnings

Upcoming earnings report

43d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.